longboardpharma.com (LBPH) - Uzoq muddatli majburiyatlarning kapitalga nisbati

Longboard Pharmaceuticals - LBPH emitenti grafik logotipi

Longboard Pharmaceuticals (LBPH) noyob patentlangan texnologiyalardan foydalangan holda, bolalardagi tutqanoqlar uchun innovatsion davolash vositalarini ishlab chiqishga ixtisoslashgan. Ushbu narxlar grafigi asosiy dori nomzodi uchun yakuniy bosqichdagi sinovlarning boshlanishini aks ettiradi, 0.01 ko'rsatkichi esa joriy tendentsiyani ifodalaydi. Biroq, geosiyosiy beqarorlik va savdo cheklovlari xalqaro dori ro'yxatdan o'tkazish va ilmiy hamkorlikni sezilarli darajada sekinlashtirmoqda.

Longboard Pharmaceuticals Inc (LBPH): Uzoq muddatli qarzning o'z kapitaliga nisbati 04.07.2022dan 07.12.2024gacha

Longboard Pharmaceuticals kompaniyasining tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Aksiya kursi Longboard Pharmaceuticals Inc|LBPH - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi ko'rsatkichlari:
Bozor qiymati Longboard Pharmaceuticals, Inc.|LBPH - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- xususiy kapitalning balans qiymati ko'rsatkichlari:
Bitta aksiya hisobiga balans qiymati Longboard Pharmaceuticals|LBPH - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor qiymati longboardpharma.com|LBPH - Kompaniyaning jami aktivlari
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Longboard Pharmaceuticals|LBPH - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati longboardpharma.com|LBPH - Kompaniya qarzlari|Balans qiymatiga qarzlar Longboard Pharmaceuticals, Inc.|LBPH - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Longboard Pharmaceuticals|Kritik likvidlik longboardpharma.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
LBPH - Sof foyda
Kompaniyaning har tomonlama tahlili:LBPH (Longboard Pharmaceuticals Inc)
longboardpharma.com original mahsuloti

Asosiy katalizatorlari 3-bosqich klinik sinovlari bo'lgan Longboard Pharmaceuticals uchun uzoq muddatli qarzdorlikning kapitalga nisbati pipeline rivojlanishining qarz mablag'lariga bog'liqligini belgilaydi. Ushbu ko'rsatkich bir yildan ortiq muddatga ega majburiyatlarning kapitalga nisbati sifatida hisoblanadi. GURU.Markets platformasida uzoq muddatli qarzning leveraj ko'rsatkichini tahlil qilish orqali investorlar qarz yuklamasi dinamikasini ko'rishlari mumkin. Bu ularga qo'shimcha aksiyalar chiqarish paytida aksiyalar qiymatining kamayishi (dilution) xavfini baholash imkonini beradi. Past leveraj biznesning moliyaviy barqarorligini tasdiqlaydi.

Raqobatdosh kompaniyalar tahlili

Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|Uzoq muddatli qarzning o'z kapitaliga nisbati Denali Therapeutics|Uzoq muddatli qarzning o'z kapitaliga nisbati HRMY|Uzoq muddatli qarzning o'z kapitaliga nisbati Biohaven (BHVN)|AMLX - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Trevi Pharma TRVI|PRAX: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Anavex Life Sciences - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati ceribell.com (CBLL)|PRTA: Uzoq muddatli qarzning kapitalga nisbati|ALEC (Alector) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Annexon Inc.|Uzoq muddatli majburiyatlarning kapitalga nisbati Omeros Corp. OMER|Uzoq muddatli qarzning kapitalga nisbati NGNE|Uzoq muddatli qarzning kapitalga nisbati acimmune.com (ACIU)|Uzoq muddatli qarzning o'z kapitaliga nisbati Voyager Therapeutics, Inc. VYGR|Uzoq muddatli qarzning kapitalga koeffitsiyenti NMRA|Scilex Holding Co. - Uzoq muddatli qarzning kapitalga nisbati|TVGN (Tevogen Bio Inc.) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|ACOG (alphacognition.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|cogrx.com - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Inhibikase Therapeutics, Inc.|Cassava Sciences Inc - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ASRT|COYA (coyatherapeutics.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati VTGN (Vistagen)|Uzoq muddatli qarzning kapitalga nisbati Ovid Therapeutics Inc OVID|ABOS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti CRVO (CervoMed, Inc.)|alteritytherapeutics.com (ATHE) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Clene|PEPG (PepGen Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati jupiterneurosciences.com|Uzoq muddatli qarzning kapitalga nisbati RLMD|Uzoq muddatli qarzning o'z kapitaliga nisbati Annovis Bio Inc ANVS|Uzoq muddatli qarzning kapitalga nisbati GRCE (Grace Therapeutics)|Firefly Neuro (AIFF) - Uzoq muddatli majburiyatlarning kapitalga nisbati|KLTO: Uzoq muddatli qarzning o'z kapitaliga nisbati|NRSN - Uzoq muddatli qarzning kapitalga nisbati|RVPH (Reviva Pharmaceuticals Holdings, Inc.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|MTVA: Uzoq muddatli kreditlarning kapitalga nisbati|NRXS (NeurAxis, Inc) - Uzoq muddatli qarzning kapitalga nisbati|Helius Medical Technologies Inc. (HSDT) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati PASG|Uzoq muddatli qarzning o'z kapitaliga nisbati bionomics.com.au NEUP|Uzoq muddatli qarzning kapitalga nisbati NERV (Minerva Neurosciences, Inc.)|Uzoq muddatli qarzning kapitalga nisbati Athira Pharma Inc ATHA|ADXN - Uzoq muddatli qarzning o'z kapitaliga nisbati|ALZN: Uzoq muddatli qarzning o'z kapitaliga nisbati|cyclerion.com (CYCN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|PTIX - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Pasithea Therapeutics Corp|Uzoq muddatli qarzning o'z kapitaliga nisbati CRGT|Uzoq muddatli qarzning kapitalga nisbati ATXI|Uzoq muddatli qarzning o'z kapitaliga nisbati BCLI (BrainStorm Cell Therapeutics Inc.)|Uzoq muddatli qarzning o'z kapitaliga nisbati Cara Therapeutics, Inc. CARA|CHRO (chromocell.com) - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Eliem - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti ITCI (Intra-Cellular Therapies)|Marinus (MRNS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi NKGN|NRBO (NeuroBo Pharmaceuticals) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati sagerx.com SAGE|Uzoq muddatli qarzning o'z kapitaliga nisbati SNPX (Synaptogenix)|Uzoq muddatli qarzning kapitalga nisbati Trevena Inc. (TRVN)|Uzoq muddatli qarzning o'z kapitaliga nisbati Vigil Neuroscience, Inc. VIGL|Uzoq muddatli qarzning kapitalga koeffitsiyenti WENA|CERE - Uzoq muddatli qarzning o'z kapitaliga nisbati